Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNB2 | O95067 | 1/20 | 0.72 |
| ▸ | CDK1 | P06493 | 1/20 | 0.72 |
| ▸ | CDK4 | P11802 | 1/20 | 0.72 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.72 |
| ▸ | CCND1 | P24385 | 1/20 | 0.72 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.61 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.59 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.59 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.59 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | SRC | P12931 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29537861 | 1.00 | CCNB2 (0.72) | CCNB2CDK1CDK4CCNB1CCND1 | |
| Fluoride SCHEMBL27920182 | 0.98 | CCNB2 (0.70) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL11614404 | 0.94 | ALDH1A1 (0.70) | CCNB2CDK1CDK4CCNB1CCND1 | |
| Butanedione SCHEMBL11053048 | 0.92 | CCNB2 (0.62) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL28304736 | 0.90 | CCNB2 (0.59) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL16632655 | 0.90 | CCNB2 (0.59) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL11452343 | 0.89 | CCNB2 (0.59) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL28184451 | 0.88 | CCNB2 (0.58) | CCNB2CDK1CDK4CCNB1CCND1 | |
| Tetrahydrofuran SCHEMBL28719419 | 0.87 | CCNB2 (0.57) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL23395754 | 0.87 | ALDH1A1 (0.61) | CCNB2CDK1CDK4CCNB1CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 909 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | claimed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | claimed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | claimed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | claimed |
| CN-105541565-B | It is a kind of to prepare 1- benzyloxies -2-[2-（3- methoxyphenyls）Yi Xiji ]The method of benzene | 苏州诚和医药化学有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-105439828-B | Synthesize 1- benzyloxies -2-[2-（3- methoxyphenyls）Yi Xiji ]The method of benzene | 苏州诚和医药化学有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-105541566-B | A kind of synthesis 1- benzyloxies -2-[2-（3- methoxyphenyls）Yi Xiji ]The method of benzene | 苏州诚和医药化学有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-105906486-B | The synthetic method of Sarpogrelate intermediate 2 [2 (3 methoxyphenyl) ethyl] phenol | 安徽修制药有限公司 | 2018-04-20 | — | — | CN | claimed |
| WO-2016161086-A1 | METHODS AND COMPOSITIONS FOR TREATING GLYCOGEN STORAGE DISEASES USING AGENTS THAT MIMIC OR ELEVATE CYCLIC AMP | DUKE UNIVERSITY (US) | 2016-10-06 | — | — | WO | claimed |
| US-20020065230-A1 | Protease inhibitors | SMITHKLINE BEECHAM CORPORATION | 2002-05-30 | — | — | US | claimed |
| US-6210816-B1 | Translucent xerographic recording substrates | XEROX CORPORATION | 2001-04-03 | — | — | US | claimed |
| EP-1074539-A2 | Process for producing optically active 3,3,3,-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-02-07 | — | — | EP | claimed |
| CN-1255119-A | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 2000-05-31 | — | — | CN | claimed |
| EP-0983228-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-03-08 | — | — | EP | claimed |
| WO-1998050342-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-12 | — | — | WO | claimed |
| EP-0666840-A1 | BENZYLAMINE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-08-16 | — | — | EP | claimed |
| WO-1995006630-A1 | BENZYLAMINE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-09 | — | — | WO | claimed |
| US-4473484-A | PHOTOISOMERIZABLE MATERIAL, PHOTOSENSITIZER, AND BY-PRODUCT INHIBITOR | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1984-09-25 | — | — | US | claimed |
| US-4424805-A | Solar energy system and method of use | NEARY MICHAEL P | 1984-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065230-A1 | Protease inhibitors | PRSS1, DNPEP, CTSZ | CCNB2 1899/4885CDK1 932/4885CDK4 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.